Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Active Surveillance for Low-Risk Prostate Cancer Reply
    Lellig, Katja
    Buchner, Alexander
    Stief, Christian
    UROLOGE, 2015, 54 (06): : 870 - 870
  • [32] PATIENT ACCEPTANCE OF ACTIVE SURVEILLANCE AS A TREATMENT OPTION FOR LOW-RISK PROSTATE CANCER
    Davison, B. Joyce
    Goldenberg, S. Larry
    JOURNAL OF UROLOGY, 2010, 183 (04): : E180 - E180
  • [33] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [34] Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives
    Zhu, Pingting
    Zhang, Qianqian
    Wu, Qiwei
    Shi, Guanghui
    Wang, Wen
    Xu, Huiwen
    Zhang, Li
    Qian, Meiyan
    Hegarty, Josephine
    THYROID, 2023, 33 (07) : 826 - 834
  • [35] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [36] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
  • [37] Active Surveillance for Low-Risk Prostate Cancer in Black Patients
    Butler, Santino
    Muralidhar, Vinayak
    Chavez, Janice
    Fullerton, Zoe
    Mahal, Aman
    Nezolosky, Michelle
    Vastola, Marie
    Zhao, Shuang G.
    D'Amico, Anthony V.
    Dess, Robert T.
    Feng, Felix Y.
    King, Martin T.
    Mouw, Kent W.
    Spratt, Daniel E.
    Quoc-Dien Trinh
    Nguyen, Paul L.
    Rebbeck, Timothy R.
    Mahal, Brandon A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2070 - 2072
  • [38] THE ERA OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IS HERE
    Sountoulides, Petros
    Obek, Can
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (02): : 49 - 51
  • [39] Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2019, 75 (05) : 750 - 751
  • [40] Super active surveillance for low-risk prostate cancer | Opinion: No
    Ghodoussipour, Saum
    Lebastchi, Amir
    Pinto, Peter
    Berger, Andre
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 215 - 219